Alan Walshe Thanks PPTA on Behalf of Plasma Donors And Patients Who Rely on PDMPs
Alan Walshe, Senior Vice President, Head of Global Commercial Strategy for Plasma Derived Therapies at Takeda, reposted from Anita Brikman on LinkedIn:
”This year’s Plasma Protein Forum, taking place in Washington DC, is tackling the most urgent issues facing Plasma-Derived Medicinal Products (PDMPs) including growing patient need, plasma donor health and the vital importance of partnering with regulators and other stakeholders.
Thank you Plasma Protein Therapeutics Association (PPTA) for your important work on behalf of plasma donors and patients who rely on PDMPs.”
Quoting Anita Brikman‘s post:
”Day one of the Plasma Protein Forum set a powerful tone for collaboration, innovation, and impact across the plasma community.
Plasma Protein Therapeutics Association (PPTA) Global Executive Board Chair Giles Platford began the day by reminding attendees of the importance of science-driven progress and global partnership.
Dr. Namandje Bumpus continued that discussion by delivering a collaborative keynote on regulatory excellence.
Sessions then moved to thought-provoking examinations on trade, donor health, state policy, and innovation.
Each session underscored the industry’s shared commitment to donors and patients.
A special thank you to all speakers, moderators, and sponsors who made today’s sessions and networking moments so engaging.
I am excited to see what tomorrow will bring at PPF2025.”
More from PPF2025 featured in Hemostasis Today.
-
Oct 22, 2026, 18:04Basem Goueli: Blood Clots in the NFL
-
Oct 22, 2026, 17:57Syed Ahmed: Viral Triggers of Immune Thrombocytopenia and Thrombosis
-
Oct 22, 2026, 17:49Valerie Tutwiler: Bridging Engineering and Medicine to Advance Thrombosis Research
-
Oct 22, 2026, 17:41Jesus Ardila Novoa: How Patient Education Can Transform Hemophilia Care
-
Oct 22, 2026, 17:30Filipe Gonçalves: Advancing Bleeding Disorder Diagnosis Through Multidisciplinary Collaboration
-
Oct 22, 2026, 17:17Storage Pool Deficiency An Overview of a Rare Platelet Disorder – EHC
-
Oct 22, 2026, 17:10Matthew Hazell: Optimizing the Use of Rare Red Blood Cell Units
-
Oct 22, 2026, 17:03Smita Patil: New Insights Into Platelet Alpha-Granule Secretion
-
Oct 22, 2026, 16:48Ahmed Alotaibi: Rare Rh Phenotype and Severe Fetal Anaemia